Q2 2026 activist investor campaigns targeted Northern Star Resources, Bio-Rad Laboratories, and Dynatrace after prolonged stock underperformance.
Activist Investing
August 11, 2026
Table of Contents
August 11, 2026
Several companies drew activist investor attention during the second quarter of 2026, triggering stock moves as investors reacted to new stakes, demands for higher capital returns, and calls for strategic reviews.
The most notable campaigns involved Northern Star Resources, Bio-Rad Laboratories, and Dynatrace. Each company had underperformed before the activist’s involvement, giving investors a clearer reason to price in the possibility of operational or strategic change.
Institutional purchases involving Microsoft, Alphabet, AMD, Park National, and Daikin were excluded because the available information did not establish an active campaign or specific demands directed at management.
Activist investors often target companies they believe are undervalued, poorly managed, inefficient, or strategically mispriced.
The market reaction is usually driven by the possibility that activist pressure could lead to:
The stock does not move only because an activist bought shares. It moves because investors begin pricing in the chance of change.
Activist investor built a stake worth more than A$1 billion in Northern Star Resources and called on the Australian gold miner to conduct a formal strategic review, including consideration of a sale.
Activist also pushed for changes to the board and leadership following repeated production guidance misses, operational problems, and share-price underperformance. Northern Star was already searching for a new chief executive when the campaign became public.
Northern Star shares rose approximately 13.7% in Sydney after the stake was reported, the strongest immediate reaction among the quarter’s verified activist campaigns. The shares traded at approximately A$21 during the session.
The reaction reflected the size of activist’s investment, its activist record, and the possibility that Northern Star could sell assets, restructure operations, or consider a full-company transaction. Northern Star said it was open to constructive engagement and regularly reviewed its portfolio and potential M&A opportunities with Goldman Sachs.
Key details:
An activist investor reportedly built a sizeable stake in Bio-Rad Laboratories and planned to push the diagnostics and life science tools company to improve its underperforming share price.
Bio-Rad had fallen more than 70% from its 2021 high before the activist investor’s involvement was reported. The company was dealing with weaker post-pandemic demand, lower sales and profit, and operating margins below several larger life science tools competitors.
Another potential source of value was Bio-Rad’s large investment in German laboratory equipment company Sartorius. The activist investor also reportedly held a direct stake in Sartorius, increasing speculation that it could push Bio-Rad to unlock value from that holding.
Bio-Rad shares rose approximately 13.9% on May 18 following reports of the position. The exact stake size and a detailed list of demands were not disclosed during the initial report.
Key details:
An activist investor disclosed a substantial investment in Dynatrace and pushed the software monitoring company to improve margins, accelerate share repurchases, and address its valuation discount.
The activist investor argued that Dynatrace had been incorrectly grouped with software companies considered vulnerable to artificial intelligence disruption. It said rising adoption of cloud infrastructure and AI workloads could increase demand for Dynatrace’s observability platform.
The investor identified opportunities to reduce sales and marketing expenses, expand free cash flow, and return more capital to shareholders. It urged Dynatrace to move faster on its existing $1 billion buyback authorization and argued that the company could repurchase more than $2.5 billion of shares over three years.
Dynatrace initially rose about 8% in extended trading after the stake was reported. The stock traded near $38.44 after hours. It later finished the following regular session approximately 2% higher as the broader software sector remained under pressure.
Key details:
The three largest verified reactions shared several characteristics:
Northern Star produced the strongest immediate reaction because the campaign combined a large stake with direct demands for a strategic review, board changes, and a possible sale.
Bio-Rad’s reaction was supported by its depressed valuation and the potential value of its Sartorius investment. The activist investor’s detailed plan had not been made public.
Dynatrace had the clearest operating and capital allocation proposal. The campaign specified potential cost reductions, higher free cash flow, and more than $2.5 billion in possible repurchases.
A Schedule 13D usually indicates that an investor may seek influence over strategy, management, board composition, capital allocation, or corporate structure.
A Schedule 13G generally indicates passive ownership and carries less activist significance.
None of these Q2 campaigns was initially defined by a new public 13D included in the available source material. Dynatrace’s campaign was established through Starboard’s public letter, while the Bio-Rad and Northern Star positions first became public through reports and direct statements.
Northern Star is listed primarily in Australia, so its disclosure framework differs from the U.S. 13D and 13G system.
The quarter’s verified campaigns focused on several recurring themes:
The campaigns at Northern Star and Dynatrace included particularly specific proposals. The initial intentions for Bio-Rad were less detailed, making the longer-term outcome more dependent on what the activist investor requested after establishing its position.
Activist involvement is not automatically bullish.
Risk increases when:
Bio-Rad carried greater uncertainty because the investor’s stake size and specific demands were not disclosed. Northern Star still faced operational problems that a strategic review alone would not resolve. Dynatrace needed to balance the proposed cost reductions against continued investment in growth.
After the Q2 disclosures, investors are likely to monitor:
The initial disclosure can move a stock quickly, but the larger and more durable effect depends on whether activist pressure leads to actual corporate action.
Q2 2026 showed that the strongest activist reactions occurred when a credible investor targeted a company with visible underperformance and an identifiable path to unlocking value.
Northern Star offered potential strategic and M&A changes. Bio-Rad combined a depressed share price with a valuable external investment. Dynatrace offered opportunities for cost reductions and larger capital returns.
Platforms like LevelFields track layoffs, market catalyst, activist investors, leadership changes, dividend increases, margin expansion, and stock reactions together, helping investors identify when outside pressure may become a meaningful stock catalyst.
Join LevelFields now to be the first to know about events that affect stock prices and uncover unique investment opportunities. Choose from events, view price reactions, and set event alerts with our AI-powered platform. Don't miss out on daily opportunities from 6,300 companies monitored 24/7. Act on facts, not opinions, and let LevelFields help you become a better investor.
AI scans for events proven to impact stock prices, so you don't have to.
LEARN MORE